CLINICAL RESEARCH

Study 1 : 

 A randomized open-label study to evaluate the efficacy and 
Safety of favipiravir and umifenovir as compared to favipiravir alone in moderate hospitalized adult indian covid-19 patients.

Study 2: 

Protocol title: a randomised, double-blind, placebo-controlled, phase 2 trial investigating the safety and efficacy of c21 in hospitalised subjects with covid-19 infection not requiring mechanical ventilation